GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA en liquidation (OTCPK:ELVYY) » Definitions » PB Ratio

Evolva Holding en liquidation (Evolva Holding en liquidation) PB Ratio : 3.08 (As of May. 21, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Evolva Holding en liquidation PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-21), Evolva Holding en liquidation's share price is $207.75. Evolva Holding en liquidation's Book Value per Share for the quarter that ended in Jun. 2023 was $67.39. Hence, Evolva Holding en liquidation's PB Ratio of today is 3.08.

The historical rank and industry rank for Evolva Holding en liquidation's PB Ratio or its related term are showing as below:

ELVYY' s PB Ratio Range Over the Past 10 Years
Min: 0.03   Med: 1   Max: 4.63
Current: 0.16

During the past 13 years, Evolva Holding en liquidation's highest PB Ratio was 4.63. The lowest was 0.03. And the median was 1.00.

ELVYY's PB Ratio is ranked better than
98.56% of 1323 companies
in the Biotechnology industry
Industry Median: 2.53 vs ELVYY: 0.16

During the past 12 months, Evolva Holding en liquidation's average Book Value Per Share Growth Rate was -76.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -24.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -19.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -10.70% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Evolva Holding en liquidation was 36.80% per year. The lowest was -72.70% per year. And the median was -14.40% per year.

Back to Basics: PB Ratio


Evolva Holding en liquidation PB Ratio Historical Data

The historical data trend for Evolva Holding en liquidation's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolva Holding en liquidation PB Ratio Chart

Evolva Holding en liquidation Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.24 1.19 1.46 1.19 1.14

Evolva Holding en liquidation Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.23 1.19 1.08 1.14 3.08

Competitive Comparison of Evolva Holding en liquidation's PB Ratio

For the Biotechnology subindustry, Evolva Holding en liquidation's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolva Holding en liquidation's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolva Holding en liquidation's PB Ratio distribution charts can be found below:

* The bar in red indicates where Evolva Holding en liquidation's PB Ratio falls into.



Evolva Holding en liquidation PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Evolva Holding en liquidation's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2023)
=207.75/67.39
=3.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Evolva Holding en liquidation  (OTCPK:ELVYY) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Evolva Holding en liquidation PB Ratio Related Terms

Thank you for viewing the detailed overview of Evolva Holding en liquidation's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolva Holding en liquidation (Evolva Holding en liquidation) Business Description

Traded in Other Exchanges
Address
Duggingerstrasse 23, Reinach, CHE, CH-4153
Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.

Evolva Holding en liquidation (Evolva Holding en liquidation) Headlines

From GuruFocus

Half Year 2023 Evolva Holding SA Earnings Call Transcript

By GuruFocus Research 02-13-2024